IL17A and metabolic syndrome: Delving into the mechanisms of the positive interaction between this therapeutic class and MetS is beyond the objectives of this discussion, but our data and those of others underline the relevant role of IL17A in the metabolic inflammation (meta-inflammation) of PsA, and how this knowledge can be used to guide treatment decisions [20].